DH-20931

N/A

Report date: 2025/09/01 13:59:42
NME

Base Information

Drug NameDH-20931
Drug Alias Nameantitumor agents (University Florida/Gwangju Institute of Science & Technology)DH-20931
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCeramide synthase 2 inhibitors
TargetsCeramide synthase 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of FloridaGwangju Institute of Science and Technology
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A